Search Results - "Klumb, C. E."

Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature by Maia, R C, de Meis, E, Romano, S, Dobbin, J A, Klumb, C E

“…Rosai-Dorfman disease (RDD) is a nonmalignant histiocytic disorder of unknown origin that is extremely rare. By immunohistochemistry, the RDD cells are…”
Get full text

Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells by Nakamura, K. D. M., Tilli, T. M., Wanderley, J. L., Palumbo, A., Mattos, R. M., Ferreira, A. C., Klumb, C. E., Nasciutti, L. E., Gimba, E. R.

“…Osteopontin (OPN) is a phosphoprotein that activates several aspects of tumor progression. Alternative splicing of the OPN primary transcript generates three…”
Get full text

p53 protein expression does not correlate with EBV status in childhood B non-hodgkin lymphomas by Klumb, C.E., Hassan, R., Zalcberg, I.R., Resende, L.M.M., Carriço, M.K., Maia, R.C.

“…Background The p53 tumor suppressor gene is affected in a wide range of human cancers, including hematological malignancies. This gene encodes a nuclear…”
Get full text

Retinoblastoma-related gene Rb2/P130 are rarely mutated in Burkitt's lymphoma from Brazil by KLUMB, C. E, MAGLUTA, E. P. S, REZENDE, L. M. M, APA, A. G, ALONSO, J. F. S, MAIA, R. C

“…It has been suggested that alterations of cell cycle genes probably contribute to the pathogenesis of endemic Burkitt's lymphoma (BL) in addition to c‐ MYC…”
Get full text

Long-term Outcome of Children and Adolescents Treated with the COPP–ABV Hybrid Protocol for Hodgkin's Disease: Balance of Risks by Klumb, C.E, Carriço, M.K, de Rezende, L.M.M, Byington, R, Bordallo, M.A, Bigni, R.S, Apa, A.G, Dobbin, J.A

Get full text

p53 gene analysis in childhood B non-Hodgkin's lymphoma by Klumb, C E, de Resende, L M, Tajara, E H, Bertelli, E C, Rumjanek, V M, Maia, R C

“…Mutations or deletions in the tumor-suppressor gene p53 are among the commonest genetic changes found in human neoplasms including breast, lung and bowel…”
Get full text

Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature by Maia, R C, de Meis, E, Romano, S, Dobbin, J A, Klumb, C E

“…Rosai-Dorfman disease (RDD) is a nonmalignant histiocytic disorder of unknown origin that is extremely rare. By immunohistochemistry, the RDD cells are…”
Get full text

Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region by Hassan, Rocio, Klumb, Claudete Esteves, Felisbino, Fabricio E, Guiretti, Deisy M, White, Lidia R, Stefanoff, Claudio Gustavo, Barros, Mario Henrique M, Seuanez, Hector N, Zalcberg, Ilana R

“…1 Bone Marrow Transplantation Centre (CEMO) 2 Hematology Service 3 Genetics Division, Instituto Nacional de Câncer (INCA) 4 Genetics Department, Universidade…”
Get full text

Retinoblastoma‐related geneRb2/p130 are rarely mutated in Burkitt's lymphoma from Brazil by Klumb, C.E., Magluta, E.P.S., Rezende, L.M.M., Apa, A.G., Alonso, J.F.S., Maia, R.C.

“…It has been suggested that alterations of cell cycle genes probably contribute to the pathogenesis of endemic Burkitt's lymphoma (BL) in addition to c‐MYC…”
Get full text

Modulation of reactive oxygen species by antioxidants in chronic myeloid leukemia cells enhances imatinib sensitivity through survivin downregulation by Kwee, Jolie Kiemlian, Luque, Diogo Gomes, Ferreira, Ana Carolina dos Santos, Vasconcelos, Flavia da Cunha, Silva, Karina Lani, Klumb, Claudete Esteves, Maia, Raquel Ciuvalschi

“…Survivin, a member of the inhibitor of apoptosis protein family and a target for new drugs, is modulated by reactive oxygen species in several types of…”
Get full text

Geographic variation in Epstein‐Barr virus–associated Burkitt's lymphoma in children from Brazil by Klumb, Claudete Esteves, Hassan, Rocio, De Oliveira, Deilson Elgui, De Resende, Lídia Maria Magalhães, Carriço, Maria Kadma, De Almeida Dobbin, Jane, Pombo‐De‐Oliveira, Maria S., Bacchi, Carlos E., Maia, Raquel Ciuvalschi

“…In developing countries, BL has a strong association with EBV infection during childhood. In South America, the data have shown an EBV association intermediate…”
Get full text

Treatment of children with B-cell non-Hodgkin's lymphoma in developing countries: the experience of a single center in Brazil by Klumb, Claudete Esteves, Schramm, Márcia Trindade, De Resende, Lídia Maria Magalhães, Carriço, Maria Kadma, Coelho, Arthur Moellman, de Meis, Ernesto, Ferreira, Regina Moreira, Maia, Raquel Ciuvalschi, Dobbin, Jane de Almeida

“…To treat non-Hodgkin's B-cell lymphoma (B-NHL) in children with manageable toxicity-related morbidity and without any decrease in survival. Between January…”
Get full text

Coexpression of p53 protein and MDR functional phenotype in leukemias: The predominant association in chronic myeloid leukemia by Cavalcanti, Geraldo Barroso, Vasconcelos, Flavia da Cunha, de Faria, Giselle Pinto, Scheiner, Marcos Antônio Maurício, Dobbin, Jane de Almeida, Klumb, Claudete Esteves, Maia, Raquel C.

“…Background One of the best characterized resistance mechanisms of leukemias is multidrug resistance (MDR) mediated by P‐glycoprotein (Pgp) and…”
Get full text

DNA sequence profile of TP53 gene mutations in childhood B-cell non-Hodgkin's lymphomas: prognostic implications by Klumb, Claudete Esteves, Furtado, Daniel Rodrigues, Magalhães de Resende, Lídia Maria, Carriço, Maria Kadma, Coelho, Arthur Moellman, de Meis, Ernesto, Maia, Raquel Ciuvalschi, Rumjanek, Franklin David

“…: Objectives: The TP53 gene encodes a nuclear protein implicated in the regulation of the cell cycle, DNA repair, and apoptosis. TP53 mutations and other…”
Get full text

Clinical approach to circumvention of multidrug resistance in refractory leukemic patients: association of cyclosporin A with etoposide by Maia, R C, Carriço, M K, Klumb, C E, Noronha, H, Coelho, A M, Vasconcelos, F C, Ruimanek, V M

“…Alternative therapy for refractory leukemic patients is being increasingly adopted. Circumvention of multidrug resistance represents a strategy that has been…”
Get more information

Hospital signs that everyone can understand by Klumb, E C

Get more information

Chromosome 17 abnormalities and mutation of the TP53 gene: correlation between cytogenetics, flow cytometry and molecular analysis in three cases of chronic myeloid leukemia by Otero, Luize, Cavalcanti Júnior, Geraldo Barroso, Klumb, Claudete Esteves, Scheiner, Marcos Antonio Mauricio, Magluta, Eliane Pereira Simões, Fernandez, Teresa de Souza, Silva, Maria Luiza Macedo, Pires, Virgínia, Andrade, Gabriela Vasconcelos, Maia, Raquel Ciuvalschi, Tabak, Daniel

“…Alterations involving the short arm of chromosome 17 (17p) during the progression of chronic myeloid leukemia (CML) have been described. This chromosomal…”
Get full text

EXPRESSION OF ADHESION MOLECULES IN HTLVI ASSOCIATED DISEASES by SILVA-BARBOSA, S DS, KLUMB, C E, GOMES, M H, BRANCO, R, SAVINO, W, OLIVEIRA, M SP

Get full text